PanaTimes

Saturday, Jan 22, 2022
TV

Three Sinovac Doses Fail to Protect Against Omicron in Study

Three Sinovac Doses Fail to Protect Against Omicron in Study

Two doses and a booster of the Covid-19 vaccine made by China’s Sinovac Biotech Ltd., one of the most widely used in the world, didn’t produce sufficient levels of neutralizing antibodies to protect against the omicron variant, a laboratory study found.
The research suggests that people who’ve received Sinovac’s shot, known as CoronaVac, should seek out a different vaccine for their booster: Getting Germany’s BioNTech SE’s messenger RNA as a third dose saw those previously fully vaccinated with CoronaVac significantly improve in protective levels of antibodies against omicron, according to the study from the University of Hong Kong and The Chinese University of Hong Kong.
Comments

mike 28 days ago
The discoverer of the omicron virus Dr. Angelique Coetzee on the Omicron-hysteria: “Let me be clear: Nothing I have seen in this new variant justifies extreme measures. After about five days the symptoms subside, and that's it. "

Newsletter

Related Articles

PanaTimes
×